Skip to Main Content

Tempest Therapeutics, Inc. Common Stock

TPST Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of TPST by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
TPST Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
TPST Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
TPST Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by TPST's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

TPST Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
TPST Income Statement
TPST Balance Sheet
TPST Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Bicyclic carboxamides and methods of use thereof Feb. 04, 2025
  • Patent Title: Bicyclic carboxamides and methods of use thereof Oct. 24, 2023
  • Patent Title: Bicyclic compounds and their use in the treatment of cancer Aug. 29, 2023
  • Patent Title: Triazolone compounds and uses thereof Jun. 06, 2023
  • Patent Title: Bicyclic compounds and their use in the treatment of cancer May. 02, 2023
  • Patent Title: Bicyclic carboxamides and methods of use thereof Oct. 18, 2022
  • Patent Title: Bicyclic carboxamides and methods of use thereof Sep. 13, 2022
  • Patent Title: Bicyclic compounds and their use in the treatment of cancer Jul. 20, 2021
  • Patent Title: Bicyclic carboxamides and methods of use thereof Apr. 06, 2021
  • Patent Title: Triazolone compounds and uses thereof Feb. 25, 2020
  • Patent Title: Pyrazolone compounds and uses thereof Jan. 09, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
TPST News

Recent insights relating to TPST

WallStreetBets

Number of mentions of TPST in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for TPST stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TPST

TPST Analyst Ratings

TPST Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
TPST Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $TPST stock a Buy, Sell, or Hold?

  • What is the price target for $TPST stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

TPST Top Shareholders
Shareholder
Shares Held
TPST Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $TPST stock?

  • Who owns the most shares of $TPST stock?

  • What funds own $TPST stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

TPST Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view TPST Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top